Results 31 to 40 of about 3,018,484 (379)
OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
Jurnal Farmasi Sains dan Praktis, 2020 The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions.
Dewi Latifatul Ilma +1 more
doaj +1 more source
Research Status on Off-label Use in Appraisal for Medical Malpractice [PDF]
Fayixue Zazhi, 2018 Off-label use is widely happened in medical practice. But for now, there is no clear legalistic demarcation for the behaviour of off-label use. Even in medical and legal fields, the consensus has not been reached.
LENG Bing-ning, WANG Xu
doaj +1 more source
Journal of Pediatric and Neonatal Individualized Medicine, 2014 The lack of specific drugs and labelling recommendations for the neonatal population is a long-standing problem throughout the world. With the introduction of the Paediatric Regulation in 2007, in Europe tangible steps have been made to increase clinical
Laura Cuzzolin
doaj +1 more source
Off-label drug use in an adult intensive care unit of a Brazilian hospital [PDF]
Brazilian Journal of Pharmaceutical Sciences, 2023 The objective of this study was to determine the prevalence and describe the factors associated with off-label drug use in an adult intensive care unit (ICU) of a Brazilian hospital.
Elana Figueiredo Chaves +8 more
doaj +1 more source
ZVT im AMNOG: jetzt neu mit Off-Label-Use?
Monitor Versorgungsforschung, 2023 Das AMNOG ist bekanntlich ein „lernendes System“. Doch in manchen Fällen wird dem System eine Lektion erteilt. So durch das Bundessozialgericht (BSG) im Februar 2023 im sogenannten Regadenoson-Urteil: Der Beschluss des G-BA zu diesem Wirkstoff wurde für ...
Dr. PH Andrej Rasch
doaj +1 more source
Off-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors [PDF]
, 2012 Background: Regulatory bodies including the European Medicines Agency register medications (formulation, route of administration) for specific clinical indications. Once registered, prescription is at clinicians’ discretion.
Abernethy, Amy Pickar +7 more
core +1 more source
Acta Medica Bulgarica, 2017 Despite the increasingly strict legislation on medicinal products, the „off-label use“ or „use of medicinal product outside the approved summary of product characteristics (SmPC)“ is a weak point of today’s drug regulation and raises many questions about
Drenska M., Getov I.
doaj +1 more source
Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital [PDF]
Farmacia Hospitalaria, 2015 Aim: To describe the off-label and unlicensed utilization patterns of drugs in a Brazilian pediatric hospital. Methods: The research consisted of a descriptive, prospective and cross-sectional study.
Vanessa Pereira Gomes +3 more
doaj +1 more source
Frontiers in Pharmacology, 2020 Dementia represents a global health challenge due to the increase in elderly population worldwide. In addition to memory loss, dementia often results in severe behavioral and psychological changes where pharmacological treatments might be considered in ...
Ismaeel Yunusa, Marie Line El Helou
semanticscholar +1 more source
Research and Reports in Tropical Medicine, 2020 COVID-19 is continuing as a big challenge for the globe and several types of research are continued to find safe and effective treatment and preventive options.
A. Belayneh
semanticscholar +1 more source